Related Experiment Video
Updated: Dec 30, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
FBXW7 Confers Radiation Survival by Targeting p53 for Degradation
Danrui Cui1, Xiufang Xiong2, Jianfeng Shu1
1Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China.
Abstract:
The tumor suppressor p53 plays a critical role in integrating a wide variety of stress responses. Therefore, p53 levels are precisely regulated by multiple ubiquitin ligases. In this study, we report that FBXW7, a substrate recognition component of the SKP1-CUL1-F-box (SCF) E3 ligase, interacts with and targets p53 for polyubiquitination and proteasomal degradation after exposure to ionizing radiation or etoposide. Mechanistically, DNA damage activates ATM to phosphorylate p53 on Ser33 and Ser37, which facilitates the FBXW7 binding and subsequent p53 degradation by SCFFBXW7. Inactivation of ATM or SCFFBXW7 by small molecular inhibitors or genetic knockdown/knockout approaches extends the p53 protein half-life upon DNA damage in an MDM2-independent manner. Biologically, FBXW7 inactivation sensitizes cancer cells to radiation or etoposide by stabilizing p53 to induce cell-cycle arrest and apoptosis. Taken together, our study elucidates a mechanism by which FBXW7 confers cancer cell survival during radiotherapy or chemotherapy via p53 targeting.
Insights
The FBXW7 E3 ligase targets the tumor suppressor p53 for degradation after DNA damage. Inhibiting FBXW7 stabilizes p53, enhancing cancer cell sensitivity to chemotherapy and radiotherapy.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Stress Response
Background:
- The tumor suppressor p53 is crucial for cellular stress responses and its levels are tightly regulated.
- Ubiquitin ligases play a key role in controlling p53 stability and function.
Purpose of the Study:
- To investigate the role of FBXW7, a component of the SCF E3 ligase complex, in regulating p53 stability.
- To elucidate the mechanism by which FBXW7 targets p53 for degradation following DNA damage.
Main Methods:
- Investigated the interaction between FBXW7 and p53 after exposure to ionizing radiation or etoposide.
- Utilized small molecular inhibitors and genetic knockdown/knockout approaches to inactivate ATM and SCFFBXW7.
- Assessed p53 protein half-life, cell-cycle arrest, and apoptosis in cancer cells.
Main Results:
- FBXW7 directly interacts with and targets p53 for polyubiquitination and proteasomal degradation.
- DNA damage activates ATM, which phosphorylates p53, facilitating FBXW7 binding and p53 degradation.
- Inactivation of ATM or FBXW7 extends p53 half-life independently of MDM2, sensitizing cancer cells to DNA-damaging agents.
Conclusions:
- FBXW7 acts as a critical regulator of p53 stability in response to DNA damage.
- Targeting FBXW7 can enhance the efficacy of radiotherapy and chemotherapy by stabilizing p53.
- This mechanism highlights a novel pathway for controlling p53 and offers therapeutic potential in cancer treatment.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway
Negative Regulator Molecules
Other Unique Bacteria

